Voyager Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
VYGR Nasdaq 2834 www.voyagertherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Voyager Therapeutics, Inc.

Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut - Mar 22nd, 2026 9:03 pm
Does Voyager Therapeutics’ (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline? - Mar 12th, 2026 4:06 pm
Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates - Mar 9th, 2026 3:15 pm
Voyager Therapeutics: Q4 Earnings Snapshot - Mar 9th, 2026 2:22 pm
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Mar 9th, 2026 2:01 pm
Voyager Therapeutics Touts Tau, Gene Therapy and NeuroShuttle Roadmap, Sees Cash Runway Into 2028 - Mar 2nd, 2026 3:03 am
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Lag Estimates - Feb 26th, 2026 7:55 am
Voyager to Present at Upcoming Investor Conferences - Feb 9th, 2026 6:00 am
Gene Therapy Market Outlook 2026-2031, Featuring Profiles of REGENXBIO, Oxford Biomedica, Voyager Therapeutics and More - Jan 23rd, 2026 4:01 am
Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage - Dec 10th, 2025 12:14 pm
We're A Little Worried About Voyager Therapeutics' (NASDAQ:VYGR) Cash Burn Rate - Nov 24th, 2025 5:21 am
Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates - Nov 10th, 2025 7:15 am
Voyager Therapeutics: Q3 Earnings Snapshot - Nov 10th, 2025 6:14 am
Voyager Reports Third Quarter 2025 Financial and Operating Results - Nov 10th, 2025 6:01 am
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia - Nov 10th, 2025 6:01 am
Moderna (MRNA) Reports Q3 Loss, Tops Revenue Estimates - Nov 6th, 2025 6:15 am
Owning 44% shares,institutional owners seem interested in Voyager Therapeutics, Inc. (NASDAQ:VYGR), - Oct 28th, 2025 5:52 am
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock? - Oct 9th, 2025 8:19 am
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst - Sep 15th, 2025 12:00 pm
Voyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2025 3:30 pm